A detailed history of Great West Life Assurance CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Great West Life Assurance CO holds 767,792 shares of LLY stock, worth $612 Million. This represents 1.31% of its overall portfolio holdings.

Number of Shares
767,792
Previous 718,779 6.82%
Holding current value
$612 Million
Previous $559 Million 24.59%
% of portfolio
1.31%
Previous 1.13%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $35.5 Million - $44.6 Million
49,013 Added 6.82%
767,792 $696 Million
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $6.55 Million - $8.76 Million
11,054 Added 1.56%
718,779 $559 Million
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $9.6 Million - $11.3 Million
-18,280 Reduced 2.52%
707,725 $411 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $1.51 Million - $2.08 Million
3,476 Added 0.48%
726,005 $390 Million
Q2 2023

Aug 10, 2023

BUY
$350.74 - $468.98 $48.9 Million - $65.4 Million
139,439 Added 23.91%
722,529 $340 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $2.9 Million - $3.41 Million
9,341 Added 1.63%
583,090 $200 Million
Q4 2022

Feb 10, 2023

SELL
$321.55 - $374.67 $16.2 Million - $18.9 Million
-50,484 Reduced 8.09%
573,749 $211 Million
Q3 2022

Nov 01, 2022

SELL
$296.48 - $337.87 $1.72 Million - $1.96 Million
-5,805 Reduced 0.92%
624,233 $202 Million
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $176 Million - $206 Million
630,038 New
630,038 $205 Million
Q2 2022

Aug 09, 2022

SELL
$278.73 - $327.27 $213 Million - $250 Million
-764,176 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$234.69 - $291.66 $2.44 Million - $3.03 Million
-10,387 Reduced 1.34%
764,176 $231 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $3.98 Million - $4.94 Million
-17,721 Reduced 2.24%
774,563 $213 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $733,052 - $902,124
3,308 Added 0.42%
792,284 $184 Million
Q2 2021

Aug 11, 2021

BUY
$180.55 - $233.54 $307,657 - $397,952
1,704 Added 0.22%
788,976 $181 Million
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $4.55 Million - $5.89 Million
-27,669 Reduced 3.4%
787,272 $146 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $7.7 Million - $10.2 Million
58,985 Added 7.8%
814,941 $137 Million
Q3 2020

Nov 17, 2020

SELL
$146.22 - $169.13 $1.9 Million - $2.19 Million
-12,964 Reduced 1.69%
755,956 $112 Million
Q3 2020

Nov 13, 2020

BUY
$146.22 - $169.13 $2.32 Million - $2.69 Million
15,891 Added 2.11%
768,920 $114 Million
Q2 2020

Aug 17, 2020

BUY
$136.42 - $164.18 $382,658 - $460,524
2,805 Added 0.37%
753,029 $123 Million
Q1 2020

May 14, 2020

BUY
$119.05 - $147.35 $5.08 Million - $6.29 Million
42,658 Added 6.03%
750,224 $105 Million
Q4 2019

Feb 11, 2020

SELL
$106.92 - $132.43 $30.6 Million - $37.9 Million
-286,174 Reduced 28.8%
707,566 $93 Million
Q3 2019

Oct 25, 2019

SELL
$106.79 - $116.16 $3.61 Million - $3.93 Million
-33,833 Reduced 3.29%
993,740 $111 Million
Q2 2019

Jul 31, 2019

BUY
$110.79 - $129.32 $29.4 Million - $34.4 Million
265,621 Added 34.86%
1,027,573 $0
Q1 2019

May 08, 2019

BUY
$111.31 - $131.02 $9.1 Million - $10.7 Million
81,768 Added 12.02%
761,952 $98.6 Million
Q4 2018

Feb 12, 2019

SELL
$105.9 - $118.64 $23.3 Million - $26.1 Million
-220,031 Reduced 24.44%
680,184 $75 Million
Q3 2018

Nov 13, 2018

SELL
$85.86 - $107.31 $6.42 Million - $8.02 Million
-74,773 Reduced 7.67%
900,215 $96.7 Million
Q2 2018

Aug 10, 2018

BUY
$75.7 - $86.88 $6.54 Million - $7.5 Million
86,352 Added 9.72%
974,988 $83.2 Million
Q1 2018

May 10, 2018

BUY
$74.21 - $87.6 $656,239 - $774,646
8,843 Added 1.01%
888,636 $68.9 Million
Q4 2017

Feb 09, 2018

SELL
$81.94 - $87.89 $9.3 Million - $9.97 Million
-113,489 Reduced 11.43%
879,793 $74.3 Million
Q3 2017

Nov 09, 2017

BUY
$77.07 - $85.54 $76.6 Million - $85 Million
993,282
993,282 $84.3 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $758B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.